Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis

Journal of Bone and Mineral Research

Volumn 20, Issue 9, 2005, Pages 1692-1699

  Amcheslavsky, Alla ^a   Hemmi, Hiroaki ^b   Akira, Shizuo ^b,c   Bar Shavit, Zvi ^a,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d NONE   (Israel)

Author keywords

Bacterial DNA; Knockout; Osteoblasts; Osteoclasis; Toll like receptors

Indexed keywords

OLIGODEOXYNUCLEOTIDE CPG; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OSTEOCLAST DIFFERENTIATION FACTOR; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; BONE DEVELOPMENT; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; GENE EXPRESSION REGULATION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE TECHNIQUES; CPG ISLANDS; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; OSTEOBLASTS; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TIME FACTORS; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24144477252     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050515     Document Type: Article

References (46)

1. Kaisho T, Akira S 2000 Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 20:393-405.
2. Akira S, Takeda K, Kaisho T 2001 Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680.
3. Takeda K, Kaisho T, Akira S 2003 Toll-like receptors. Annu Rev Immunol 21:335-376.
4. Aderem A, Hume DA 2000 How do you see CG? Cell 103:993-996.
5. Krieg AM 2001 Now I know my CpGs. Trends Microbiol 9:249-252.
6. Wagner H 2001 Toll meets bacterial CpG-DNA. Immunity 14:499-502.
7. Wagner H 2004 The immunobiology of the TLR9 subfamily. Trends Immunol 25:381-386.
8. Krieg AM 2003 CpG motifs: The active ingredient in bacterial extracts? Nat Med 9:831-835.
9. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H 2002 Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 32:1958-1968.
10. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT 2004 TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5:190-198.
11. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B, Monefeldt K, Tollefsen T 1996 Bacterially induced bone destruction: Mechanisms and misconceptions. Infect Immun 64:2371-2380.
12. Henderson B, Nair SP 2003 Hard labour: Bacterial infection of the skeleton. Trends Microbiol 11:570-577.
13. Dickinson CJ 2000 The possible role of osteoclastogenic oral bacterial products in etiology of Paget's disease. Bone 26:101-102.
14. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B 1998 Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 28:2085-2088.
15. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y 2001 Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 166:3574-3579.
16. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL 1997 Lipopolysaccharide- stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557-1565.
17. Jiang J, Zuo J, Hurst IR, Holliday LS 2003 The synergistic effect of peptidoglycan and lipopolysaccharide on osteoclast formation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:738-743.
18. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S 2000 A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
19. Zou W, Schwartz H, Endres S, Hartmann G, Bar-Shavit Z 2002 CpG oligonucleotides: Novel regulators of osteoclast differentiation. FASEB J 16:274-282.
20. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
21. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elllott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
22. Amcheslavsky A, Zou W, Bar-Shavit Z 2004 Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis. J Biol Chem 279:54039-54045.
23. Zou W, Amcheslavsky A, Bar-Shavit Z 2003 CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 278:16732-16740.
24. Yi AK, Peckham DW, Ashman RF, Krieg AM 1999 CpG DNA rescues B cells from apoptosis by activating NF-κB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 11:2015-2024.
25. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL 2000 Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440.
26. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
27. Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z 2001 Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83:70-83.
28. Doyle A, Griffiths JB, Newell DG 1996 Cell and Tissue Culture: Laboratory Procedures, 1st ed. John Wiley & Sons Ltd., West Sussex, UK.
29. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T 2000 Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484.
30. Udagawa N, Chan J, Wada S, Findlay DM, Hamilton JA, Martin TJ 1996 c-Fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro. Bone 8:511-516.
31. Zou W, Bar-Shavit Z 2002 Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218.
32. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
33. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH 2002 The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30:71-77.
34. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N, Baek JH 2002 p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143:3105-3113.
35. Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M 2000 Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem 275:31155-31161.
36. Iino Y, Hopps RM 1984 The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths. Arch Oral Biol 29:59-63.
37. Hausmann E, Raisz LG, Miller WA 1970 Endotoxin: Stimulation of bone resorption in tissue culture. Science 168:862-864.
38. Greenfield EM, Bi Y, Ragab AA, Goldberg VM, Van De Motter RR 2002 The role of osteoclast differentiation in aseptic loosening. J Orthop Res 20:1-8.
39. Takami M, Kim N, Rho J, Choi Y 2002 Stimulation by Toll-like receptors inhibits osteoclast differentiation. J Immunol 169:1516-1523.
40. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H 2003 Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J Immunol 71:5130-5139.
41. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL 2000 TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488.
42. Hudsona F, Rampb WK, Nicholsonb NC, Williams AS, Nousiainen MT 1995 Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog 19:409-419.
43. Alexander EH, Bento JL, Hughes FM Jr, Marriott I, Hudson MC, Bost KL 2001 Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumour necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun 69:1581-1586.
44. Davis HL 2000 Use of CpG DNA for enhancing specific immune responses. Curr Top Microbiol Immunol 247:171-183.
45. Krieg AM 2002 CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760.
46. Klinman DM 2003 CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2:305-315.